IMI2 – 20th Call for proposals

Call ID: H2020-JTI-IMI2-2020-20-two-stage
Action Type: RIA – Research and Innovation Actions

The Innovative Medicines Initiative (IMI) has now launched its 20 th Call for proposals under IMI2. The Call gives researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that ill pave the way for the development of the medicines of the future.

Topics

• Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
• Topic 2: Innovations to accelerate vaccine development and manufacture
• Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
  This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019).
• Topic 4: Tumour plasticity
• Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
• Topic 6: Handling of protein drug products and stability concerns

How to apply

All documents relating to the Call can be found via the Funding and Tenders Portal and the IMI2 Call documents page, in particular the IMI Manual for evaluation, submission and grant award – version 1.7.

Short proposals must be submitted via the electronic submission system of the Funding and Tenders Portal. To start submitting your proposal, simply click on the relevant topic above – this will take you directly to that topic’s page on the Participant Portal. Once there, scroll down and click on ‘Start submission’.

Detailed guidance on how to submit a proposal, including a detailed user manual and frequently asked questions, can be found under the Submit a Proposal section of the Participant Portal Horizon 2020 Online Manual.

To submit a proposal via the electronic submission system, applicants will need to have an EU Login account and ensure that their organisation is registered as a beneficiary.

Deadline for short proposals (Stage 1) : 21 April 2020